America authorizes the first smart application that controls insulin pump doses for diabetics
The US Food and Drug Administration has authorized the first application on smartphones, intended to help diabetics program and cancel insulin doses from a pump.
And the company "Tandem Diabetes Care" said in a statement, the day before yesterday, Wednesday, that the Food and Drug Administration has approved its smart application "t: connect" from the insulin pump "t: Slim X2".
The company claims that it is the first time that the US Food and Drug Administration has approved a phone app for this purpose.
The t:connect mobile application, available on iPhone and Android phones, will enable diabetics to program and cancel corrective insulin doses from the pump.
When connected to the pump, the app can display information about a patient's last 24 hours of glucose trends and changes in status, including alerts and alerts, as well as insulin therapy data. Patients will be able to use their phones to determine how much insulin they need and then program their dose.
It is possible that the US Food and Drug Administration's approval of the application is a step towards a more diabetic-friendly way to manage insulin doses.
Follow our latest local and sports news and the latest political and economic developments via Google news